Al-Kali A, Tibes R, Atherton P, Palmer J, et al. A Phase II Study of Combination Daunorubicin, Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia with KIT Expression. Am J Hematol 2023 Jan 9. doi: 10.1002/ajh.26831.
PMID: 36625066